Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Medicell Technologies LLC is currently managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This single matter is being handled by 1 distinct examiner, YU, HONG, who is also the busiest examiner for the portfolio with 1 pending case. The company's active prosecution is localized in 1 distinct art unit, reflecting a concentrated technical focus for its current filings.
The alignment of 1 pending office action with a single distinct examiner and 1 distinct art unit creates a streamlined prosecution environment. For a practitioner, this means that all current strategic efforts are focused on the examination style of YU, HONG. This high level of concentration in the Biotechnology & Pharmaceuticals sector suggests a targeted approach to securing intellectual property for a specific technology or application.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YU, HONG | 1 | 30.9% | +5.6% |
| Art Unit | Apps |
|---|---|
| 1614 | 1 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial